Jeffrey Alan Jones, Chief Medical Officer of Cullinan Therapeutics ($CGEM), sold shares on the open market three times in the last year, totaling nearly $179,000. His most recent sale occurred on February 24, 2026. These sales rank 8,668th among 11,678 individual insiders, compared to an average of $8.6 million per insider and 6.4 transactions. Jones made no open market purchases in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 24, 2026 | Cullinan Therapeutics, Inc. | $CGEM | Jones Jeffrey Alan | Chief Medical Officer | S | Common Stock | 4582 | $14.47 | 159,968.0000 | 59,076,259 | 2.78% | 0.01% |
| Feb. 20, 2026 | Cullinan Therapeutics, Inc. | $CGEM | Jones Jeffrey Alan | Chief Medical Officer | S | Common Stock | 4982 | $13.62 | 164,550.0000 | 59,076,259 | 2.94% | 0.01% |
| Feb. 18, 2026 | Cullinan Therapeutics, Inc. | $CGEM | Jones Jeffrey Alan | Chief Medical Officer | A | Stock Option (Right to Buy) | 300000 | $0.00 | 300,000.0000 | 59,076,259 | 9999.99% | 0.51% |
| Dec. 18, 2025 | Cullinan Therapeutics, Inc. | $CGEM | Jones Jeffrey Alan | Chief Medical Officer | S | Common Stock | 4632 | $9.67 | 169,532.0000 | 59,076,259 | 2.66% | 0.01% |
| Feb. 25, 2025 | Cullinan Therapeutics, Inc. | $CGEM | Jones Jeffrey Alan | Chief Medical Officer | S | Common Stock | 4895 | $8.53 | 174,164.0000 | 58,510,610 | 2.73% | 0.01% |
| Feb. 19, 2025 | Cullinan Therapeutics, Inc. | $CGEM | Jones Jeffrey Alan | Chief Medical Officer | A | Common Stock | 65000 | $0.00 | 179,059.0000 | 58,510,610 | 56.99% | 0.11% |
| Feb. 19, 2025 | Cullinan Therapeutics, Inc. | $CGEM | Jones Jeffrey Alan | Chief Medical Officer | A | Stock Option (Right to Buy) | 130000 | $0.00 | 130,000.0000 | 58,510,610 | 9999.99% | 0.22% |
| Dec. 18, 2024 | Cullinan Therapeutics, Inc. | $CGEM | Jones Jeffrey Alan | Chief Medical Officer | S | Common Stock | 4632 | $11.41 | 114,059.0000 | 42,900,083 | 3.90% | 0.01% |
| Feb. 22, 2024 | Cullinan Therapeutics, Inc. | $CGEM | Jones Jeffrey Alan | Chief Medical Officer | A | Stock Option (Right to Buy) | 125000 | $0.00 | 125,000.0000 | 42,900,083 | 9999.99% | 0.29% |
| Feb. 22, 2024 | Cullinan Therapeutics, Inc. | $CGEM | Jones Jeffrey Alan | Chief Medical Officer | A | Common Stock | 62500 | $0.00 | 118,691.0000 | 42,900,083 | 111.23% | 0.15% |
| Dec. 21, 2023 | Cullinan Therapeutics, Inc. | $CGEM | Jones Jeffrey Alan | Chief Medical Officer | S | Common Stock | 1860 | $8.50 | 56,191.0000 | 0 | 3.20% | 0.00% |
| Dec. 18, 2023 | Cullinan Therapeutics, Inc. | $CGEM | Jones Jeffrey Alan | Chief Medical Officer | S | Common Stock | 386 | $8.22 | 58,051.0000 | 0 | 0.66% | 0.00% |
| June 20, 2023 | Cullinan Therapeutics, Inc. | $CGEM | Jones Jeffrey Alan | Chief Medical Officer | S | Common Stock | 387 | $12.94 | 58,437.0000 | 0 | 0.66% | 0.00% |
| May 18, 2023 | Cullinan Therapeutics, Inc. | $CGEM | Jones Jeffrey Alan | Chief Medical Officer | S | Common Stock | 394 | $8.76 | 58,824.0000 | 0 | 0.67% | 0.00% |
| April 18, 2023 | Cullinan Therapeutics, Inc. | $CGEM | Jones Jeffrey Alan | Chief Medical Officer | S | Common Stock | 392 | $10.71 | 59,218.0000 | 0 | 0.66% | 0.00% |
| March 20, 2023 | Cullinan Therapeutics, Inc. | $CGEM | Jones Jeffrey Alan | Chief Medical Officer | S | Common Stock | 390 | $11.32 | 59,610.0000 | 0 | 0.65% | 0.00% |
| Feb. 17, 2023 | Cullinan Therapeutics, Inc. | $CGEM | Jones Jeffrey Alan | Chief Medical Officer | A | Stock Option (Right to Buy) | 120000 | $0.00 | 120,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 17, 2023 | Cullinan Therapeutics, Inc. | $CGEM | Jones Jeffrey Alan | Chief Medical Officer | A | Common Stock | 60000 | $0.00 | 60,000.0000 | 0 | 9999.99% | 0.00% |